SnakeBite911 4.4.7

The SnakeBite911 app offers a comprehensive solution by merging several existing applications into one streamlined tool. It presents a sleek design along with a newly added emergency feature for rapid access to essential functionalities.

This informative guide serves as a valuable resource to educate users about venomous pit viper snakes prevalent in North America, such as rattlesnakes, copperheads, and cottonmouths. It covers strategies for avoiding encounters with these snakes, as well as providing guidance on handling snakebite incidents effectively.

The app is designed to operate even without an active internet connection, ensuring accessibility in critical situations.

Key Features:

• Emergency support for snakebite situations
• Direct dialing of emergency services
• Detailed list of recommended actions for aiding snakebite victims
• Venom Tracker tool for documenting venom distribution, facilitating quicker diagnosis and treatment upon arrival at the emergency room
• Information on North American venomous snakes and their identification
• Guidance on preventive measures to avoid snake encounters

The developers of the SnakeBite911 app have a background in manufacturing CroFab® CrotalidaePolyvalent Immune Fab (Ovine), an antivenin derived from sheep indicated for treating North American crotalid envenomations. The term "crotalid" refers to venomous snakes within the Crotalinae subfamily which encompass rattlesnakes, copperheads, and cottonmouths/water moccasins.

Important Safety Information:

CONTRAINDICATIONS: CroFab® should not be administered to patients with known hypersensitivity to any of its components, papaya, or papain unless the benefits clearly outweigh the risks.

WARNINGS AND PRECAUTIONS:

• CroFab® may cause recurrent coagulopathy in patients treated for snakebites, necessitating careful monitoring and potential retreatment.
• Patients should be assessed for hypersensitivity reactions during and after CroFab® administration, with appropriate emergency measures readily available.

Adverse Reactions:

The most common adverse reactions reported during clinical studies included urticaria, rash, nausea, pruritus, and back pain. Skin-related adverse events were prevalent among patients, warranting close observation post-treatment.

To access complete Prescribing Information and report adverse reactions, visit www.CroFab.com or contact 1-877-377-3784 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.